Paul K.J.D. de Jonge

Author

Also Known As

P. K. J. D. De Jonge, P. K. J. D. de Jonge, P.K.J.D. De Jonge, P.K.J.D. de Jonge, Paul K J D de Jonge, Paul K. J. D. de Jonge, Paul K.J.D. de Jonge, Paul Kjd de Jonge, Paul de Jonge, de Jonge, P

Publications

486

Citations

H-Index

Concepts

All Affiliations

Radboud University Medical Center Radboud University Nijmegen Radboud Institute for Molecular Life Sciences University Medical Center Amphia Ziekenhuis

About

Paul K.J.D. de Jonge is an author at Radboud University Medical Center specializing in medicine, urology, and tissue engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	71
2	Engineering	2	2	28
3	Biomedical Engineering	2	2	28
4	Cell Biology	1	1	43
5	Immunology	1	1	43

Paul K.J.D. de Jonge

Publications

259

Citations

H-Index

Page 1

	Year	Citations
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer Ralph J. A. Maas, Janneke S. Hoogstad‐van Evert, Jolien M.R. Van der Meer, OncoImmunology	2020	65
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells Jolien M.R. Van der Meer, Ralph J. A. Maas, Karolin Guldevall, Cancer Immunology Immunotherapy Vivo Half-lifeImmunologyImmune RegulationImmunoeditingAllogeneic Natural Killer	2020	43
Visualisation of newly synthesised collagen in vitro and in vivo Corien Oostendorp, Peter J.E. Uijtdewilligen, Elly M. M. Versteeg, Scientific Reports	2016	26
Bladder Regeneration Using Multiple Acellular Scaffolds with Growth Factors in a Bladder L.A.J. Roelofs, Paul K.J.D. de Jonge, Egbert Oosterwijk, Tissue Engineering Part A	2017	22
CD34 <sup>+</sup> progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg <sup>null</sup> mice Jolien M.R. Van der Meer, Paul K.J.D. de Jonge, Anniek B. van der Waart, OncoImmunology	2021	19
Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia Paul K.J.D. de Jonge, P.M.M. van Hauten, L. D. Janssen, Cancer Immunology Immunotherapy	2023	17
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer Ralph J. A. Maas, Janneke S. Hoogstad‐van Evert, Iris M. Hagemans, Frontiers in Immunology	2024	15
Ureteral reconstruction with reinforced collagen scaffolds in a porcine model Paul K.J.D. de Jonge, V. Simaioforidis, Paul Geutjes, Journal of Tissue Engineering and Regenerative Medicine Tissue EngineeringEngineeringScaffold ImplantationCollagen-vicryl ScaffoldsBone Repair	2016	14
Ureteral Reconstruction in Goats Using Tissue-Engineered Templates and Subcutaneous Preimplantation Paul K.J.D. de Jonge, Marije Sloff, Heinz-Peter Janke, Tissue Engineering Part A Tissue EngineeringCaprineEngineeringTubular TemplatesSurgery	2017	14
The effect of a cyclic uniaxial strain on urinary bladder cells Dorien M. Tiemessen, Paul K.J.D. de Jonge, Willeke F. Daamen, World Journal of Urology	2017	12

Page 1